Drug Profile
AGL 558
Alternative Names: AGL-558Latest Information Update: 22 Jan 2007
Price :
$50
*
At a glance
- Originator Kirin Brewery
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 22 Oct 1997 No-Development-Reported for Cancer in Japan (IV)
- 08 Sep 1997 Preclinical development for Cancer in Japan (IV)